These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis.
    Author: Altunbas H, Yazicioglu G, Balci MK, Karayalçin U, Undar L.
    Journal: Int J Clin Pract; 1999; 53(5):396-7. PubMed ID: 10695110.
    Abstract:
    A 43-year-old female patient with Basedow-Graves' disease developed agranulocytosis in the eighth month of propylthiouracil therapy. After discontinuing the drug, a broad spectrum antibiotic regimen plus recombinant human granulocyte colony-stimulating factor (G-CSF), a human haematopoietic growth factor, were started. Her granulocyte count returned to normal with the second dose of G-CSF, and ulcerating pharyngitis improved rapidly. We think that in patients with propylthiouracil-induced agranulocytosis, G-CSF will reduce the risk and severity of infection, and should be accepted as a part of the standard therapy.
    [Abstract] [Full Text] [Related] [New Search]